MYD88 and hepatocellular carcinoma: In the progression of hepatocellular carcinoma, the activation of Myd88 signaling could promote the proliferation and migration of hepatitis B virus-infected LX‐2 cells, and inhibit apoptosis (Yuan et al., 2021).